Overview Fundamentals API Earnings EOD API Sample Code Pricing

Chimeric Therapeutics Limited (CHMMF PINK) stock market data APIs

$0.03 0(0%) as of July 26, 2024
Price chart is built with Anychart

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.

Chimeric Therapeutics Limited Financial Data Overview

0.03
0.03
-
0.03
0.03
0.0125-0.035
25 882 K
863 M
12 466 K
1.496
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CHMMF',
Type: 'Common Stock',
Name: 'Chimeric Therapeutics Limited',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG011P2NT50',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Chimeric Therapeutics Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 12 466 K
  • EBITDA -10 602 260
  • Earnings Per Share -0.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Chimeric Therapeutics Limited Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Chimeric Therapeutics Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com